Transasia Bio-Medicals Ltd., India’s leading in vitro diagnostic company, has introduced an advanced fully automated random access coagulation analyzer, ECL 760. With its unique 7 channel LED detection system, ECL 760 is an ideal choice for an entire spectrum of clotting, chromogenic, and immunological assays including D-Dimer. 

Proven Principle of Clot Detection

Based on the principle of percentage intensity of light scatter at 640 nm LED, ECL 760 monitors the entire clotting process end-to-end and minimizes interferences.

Advanced Sample Management

Its sophisticated software allows continuous loading and classification of samples as patient, STAT and quality control. It also allows for retest and reflex to be performed.

Comprehensive Reagent Management

The system can accept 23 reagent lot, expiry and reagent position details. Around 20 reagents have onboard cooling and stirring function. It can perform more than 10 tests/ sample.

Quality Control Management

The system offers a provision for selecting the QC execution frequency as per the standard protocol of the laboratory. It also allows reporting as L-J graphs and multi-rules plot.

 ECL 760 has been successfully installed and validated at reputed labs across the country. The prothrombin time (PT) and activated partial thromboplastin timer (APTT) reagents have shown excellence performance qualification on ECL 760. Wide array of coagulation tests, ease of use, high accuracy and precision, comprehensive presentation of QC data, throughput of 60 samples/ hour, and random test analysis are some of the features that  makes ECL 760 a trusted name for seamless operations. ”

Shivadas Pokkalath
Product Manager-Coagulation,
Transasia Bio-Medicals Ltd.


 

Digital version